AzTrials
AzTrials

Complete EdentulismFALBALANCT05162963

Impact of Removable Versus Fixed Implant-supported Prostheses in Oral Health Quality of Life for Edentulous Patients

A study testing fixed implant denture and removable implant denture in people with Complete Edentulism, run by Assistance Publique - Hôpitaux de Paris.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Comparison between fixed and removable implant-retained complete prostheses previously showed that while patients appreciate the ergonomic cleaning of removable prostheses, they prefer the comfort and masticatory efficiency of fixed prostheses. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Complete Edentulism
What is being tested?
fixed implant denture and removable implant denture
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
No sites listed yet
Study dates
1 Feb 2022to 1 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients ≥ 18 years of age;
  • Mandibular AND/OR maxillary edentulous patients, treated with satisfying conventional denture for a minimum of 3 months;
  • Bone volume compatible with the placement of implants of at least 9 mm in length;
  • Sufficient inter-arch space;
  • Free and informed consent;
  • Affiliated to the social security fund.

Who cannot join

  • Systemic pathologies contraindicating the placement of implants (unbalanced diabetes, biphosphonates);
  • Smoking patient > 10 cigarettes per day;
  • Class IV bone according to the Leckholm and Zarb classification.

Trial locations and contacts

No sites are listed yet.

Claudine Wulfman, Professor contact

33 6 58 37 21 95

claudine.wulfman@aphp.fr

About this study

Official title: Impact of Implant-supported Removable Prosthesis Versus Fixed Prosthesis on Quality of Life in Edentulous Patients: a Multicenter Non-inferiority Cross-over Trial

Comparison between fixed and removable implant-retained complete prostheses previously showed that while patients appreciate the ergonomic cleaning of removable prostheses, they prefer the comfort and masticatory efficiency of fixed prostheses. New treatment strategies are emerging; the use of telescopic attachments now offers a prosthetic alternative for the treatment of edentulous teeth at a lower financial cost than fixed prostheses.

To answer this question, the study is constructed as a cross-over. 30 patients will use a removable telescopic prosthesis and then a fixed prosthesis, or vice versa, for a period of 6 months according to randomization. They will answer a quality of life questionnaire after each period and finally choose their favorite prosthesis. The null hypothesis is that removable telescopic implant prostheses will result in a quality of life comparable to that obtained with fixed implant-supported prostheses.

Read more

The primary objective of this study is to demonstrate the non-inferiority of removable versus fixed prostheses on quality of life after 6 months of use of each implant-supported prosthesis in edentulous maxillary or mandibular patients. The measurement of the evolution of the quality of life is analyzed using the GOHAI questionnaire after 6 months of use of each prosthesis.

The secondary objectives are to:

  • Determine the decisional parameters in the final choice of the prosthesis by the patient at the end of the study, with the Mc Gill Denture Satisfaction Instrument,
  • Compare the masticatory efficiency between the two dentures (duration, number of cycles and frequency of chewing of the carrot test food, with each denture after 6 months of use),
  • Compare the oral hygiene between the two prostheses (peri-implant plaque index, after 6 months for each prosthesis),
  • Compare the adjustments and repair required after the placement of each prosthesis and the chairside treatment time to achieve them,
  • Compare the complications and their frequency of occurrence with each type of prosthesis during the 6-month wearing period.
Read the detailed description

Edentulism is defined as the loss of all natural teeth and is an important public health issue globally for its high prevalence (exceeding 10% in adults aged ≥ 50 years) and associated disability Epidemiological studies show a decrease in the prevalence of total edentulism but an increase in the number of edentulous people in the world in general and in Western society in particular, linked to the increase in life expectancy. In Europe, the edentulism rate varies greatly from one country to another. According to the WHO, in the 65+ age group, the rate of total edentulism in 2000 was 60-70% in some European countries and still 15% in France.

Prosthetic rehabilitation is a factor of social inequalities in health insofar as this care is poorly covered or not covered by social organizations. The different treatment solutions must be examined in terms of the gain they represent in terms of quality of life compared to their cost.

The improvement of retention of a removable prosthesis with implants was demonstrated. The comparison between fixed and removable implant-retained prostheses previously showed that while patients appreciate the ergonomic cleaning of removable prostheses, they prefer the comfort and masticatory efficiency of fixed prostheses. New treatment strategies are emerging; the use of telescopic attachments now offers a prosthetic alternative for the treatment of edentulous teeth at a lower financial cost than fixed prostheses. This treatment option is not well known. There are no randomized controlled studies directly comparing these two therapies in terms of quality of life.

To answer this question, the study is constructed as a cross-over. 30 patients will use a removable telescopic prosthesis and then a fixed prosthesis, or vice versa, for a period of 6 months according to randomization. They will answer a quality of life questionnaire after each period and finally choose their favorite prosthesis. The null hypothesis is that removable telescopic implant prostheses will result in a quality of life comparable to that obtained with fixed implant-supported prostheses.

The primary objective of this study is to demonstrate the non-inferiority of removable versus fixed prostheses on quality of life after 6 months of use of each implant-supported prosthesis in edentulous maxillary or mandibular patients. The measurement of the evolution of the quality of life is analyzed using the GOHAI questionnaire after 6 months of use of each prosthesis, i.e. twice during the study.

The GOHAI is a specific oral quality of life scale, comprising 12 items scored from 1 to 5 divided into 3 subparts corresponding to the functions of speaking, eating, and swallowing, psychosocial aspects, and pain/discomfort. A score of 60 corresponds to an optimal quality of life.

The secondary objectives are to:

  • Determine the decisional parameters in the final choice of the prosthesis by the patient at the end of the study, with the Mc Gill Denture Satisfaction Instrument,
  • Compare the masticatory efficiency between the two dentures (duration, number of cycles and frequency of chewing of the carrot test food, with each denture after 6 months of use),
  • Compare the oral hygiene between the two prostheses (peri-implant plaque index, after 6 months for each prosthesis),
  • Compare the adjustments and repair required after the placement of each prosthesis and the chairside treatment time to achieve them,
  • Compare the complications and their frequency of occurrence with each type of prosthesis during the 6-month wearing period.

Experimental design All patients will receive four or six dental implants, four in the mandible or six in the maxilla, depending on the arch to be treated. After an osseointegration phase of 4 to 6 months, two implant prostheses will be made for each patient, one removable, the other fixed. All patients will receive specific training in oral and peri-implant hygiene. According to the randomization, during an initial period of 6 months, half of the patients will be using the removable prosthesis, the other half the fixed prosthesis. A 15-day washout will be performed. No residual effect are expected, but the assessment of the baseline quality of life require daily use of the conventional prosthesis (without implant). Then, during a second period of 6 months, the patients will be using the second prosthesis. At the end of the study, the patient will choose the prosthesis he prefers and justifies his choice in a specific questionnaire.

A measurement of quality of life (GOHAI questionnaire) will be carried out before treatment and after use of each type of prosthesis. At the 6-month appointment of each prosthesis, evaluations will be performed including a plaque index measurement and a masticatory efficiency test. The adjustments and repairs required during the time the prosthesis will be worn, as well as the time required to perform them, will be recorded. A follow-up of the complications that occurred on each type of prosthesis will be set up during the two prosthetic phases.

The analysis will be carried out in intention-to-treat and per-protocol analysis. The treatment effect will be estimated by the difference in the evolution of the GOHAI score between the period with a removable prosthesis and the period without a removable prosthesis and its 95% confidence interval. A sequence and carry over effect will be sought.

Being tested
fixed implant denture, removable implant denture
Keywords
Overdenture, Complete edentulism, Quality of life, Dental implant

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • fixed implant dentureOther

    Patients will receive four or six dental implants, four in the mandible or six in the maxilla, depending on the arch to be treated. After an osseointegration phase of 4 to 6 months, two implant prostheses will be made for each patient, one removable, the other fixed. According to the randomization, during an initial period of 6 months, half of the patients will be using the removable prosthesis, the other half the fixed prosthesis. A 15-day washout will be performed. Then, during a second period of 6 months, the patients will be using the second prosthesis.

  • removable implant dentureOther

    removable implant denture

Study groups in NCT05162963
Study groupRoleWhat they receive
Patients treated with fixed implant dentureActive comparatorPatients quality of life will be compared when using a removable implant denture and a fixed implant denture, in a cross-over design. Fixed denture is considered the standard protocol.
Receives: Other: fixed implant denture; Other: removable implant denture
Patients treated with removable implant dentureExperimentalPatients quality of life will be compared when using a removable implant denture and a fixed implant denture, in a cross-over design. Removable denture is considered the experimental protocol.
Receives: Other: fixed implant denture; Other: removable implant denture

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measurement of the evolution of the quality of life using the GOHAI questionnaire

    Measurement of the evolution of the quality of life is analyzed using the GOHAI questionnaire

    Measured: 6 months

Secondary outcomes (7)
  1. Scores of the Mc Gill Denture Satisfaction Instrument

    Scores of the Mc Gill Denture Satisfaction Instrument, for the final choice of prosthesis, at the end of the study.

    Measured: 21 months

  2. Measurement of the duration of chewing of the carrot test food

    Measurement of the duration of chewing of the carrot test food at the swallowing threshold, after 6 months, for each prosthesis;

    Measured: 6 months

  3. Measurement of the number of cycles of chewing of the carrot test food

    Measurement of the number of cycles and frequency of chewing of the carrot test food at the swallowing threshold, after 6 months, for each prosthesis;

    Measured: 6 months

  4. Measurement of the frequency of chewing of the carrot test food

    Measurement of the frequency of chewing of the carrot test food at the swallowing threshold, after 6 months, for each prosthesis;

    Measured: 6 months

  5. Peri-implant plaque index

    Peri-implant plaque index (measured by the Mombelli score), after 6 months for each prosthesis

    Measured: 6 months

  6. Adjustments required after placement

    Adjustments required after placement, with each prosthesis (subprosthetic injuries, premature and occlusal interferences, retouching of the prosthetic intrados or extrados, adjustment of the retention force, modification of the prosthetic profile), during the 6-month wearing period for each prosthesis; The time of adjustment is measured from the moment the patient sits in the dental chair to the moment he/she leaves the chair, the unit is the quarter hour;

    Measured: 6 months

  7. Complications

    Complications (screw fractures, prosthetic screw loosening, ceramic fracture, prosthetic base fracture, attachment loss, abutment screw loosening, implant loss), during the 6-month wearing period, for each prosthesis.

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Dec 2021
  2. Study start1 Feb 2022 (estimated)
  3. Primary completion1 Apr 2024 (estimated)
  4. Study completion1 May 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
36 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05162963
Sponsor's protocol ID
APHP210087
Acronym
FALBALA
Status last verified
May 2021
First submitted
6 Dec 2021
Last updated
20 Dec 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: DATAS ARE OWN BY ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS, PLEASE CONTACT SPONSOR FOR FURTHER INFORMATION

Questions about this trial

What is this clinical trial studying?

A study testing fixed implant denture and removable implant denture in people with Complete Edentulism, run by Assistance Publique - Hôpitaux de Paris.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Dec 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Claudine Wulfman, Professor (33 6 58 37 21 95, claudine.wulfman@aphp.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measurement of the evolution of the quality of life using the GOHAI questionnaire (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Dec 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in